Aquatic Capital Management LLC Boosts Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Aquatic Capital Management LLC grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 309.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,458 shares of the biotechnology company’s stock after purchasing an additional 23,018 shares during the period. Aquatic Capital Management LLC’s holdings in Axon Enterprise were worth $18,102,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Friedenthal Financial increased its stake in Axon Enterprise by 961.7% in the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock worth $808,000 after buying an additional 1,231 shares during the period. Principal Financial Group Inc. grew its stake in Axon Enterprise by 33.1% in the 3rd quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock worth $54,466,000 after acquiring an additional 33,869 shares in the last quarter. Artemis Investment Management LLP raised its holdings in shares of Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock valued at $56,528,000 after acquiring an additional 16,792 shares in the last quarter. Decker Retirement Planning Inc. purchased a new stake in Axon Enterprise in the fourth quarter worth about $2,985,000. Finally, MRA Advisory Group increased its position in Axon Enterprise by 64.4% during the 4th quarter. MRA Advisory Group now owns 3,205 shares of the biotechnology company’s stock valued at $1,905,000 after purchasing an additional 1,255 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $603.78 on Friday. The stock has a market cap of $47.00 billion, a PE ratio of 156.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 52-week low of $273.52 and a 52-week high of $715.99. The business has a 50-day simple moving average of $545.51 and a 200-day simple moving average of $570.72. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the transaction, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

AXON has been the topic of a number of recent research reports. Needham & Company LLC reiterated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a report on Monday, March 10th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. Northcoast Research downgraded shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Barclays reiterated a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $626.45.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.